BioInsights - Vol 7 Issue 10

CELL & GENE THERAPY INSIGHTS

Vol 7 Issue 10

Cell & Gene Therapy Vol 7 Issue 10

Download PDF

Featuring

Issue Spotlight: New horizons for cell therapy: emerging platforms
Focus: Raw Material Sourcing
Other articles

New horizons for cell therapy: emerging platforms

Editorial

A model for where we live

A model for where we live

Jared Burks

25 November 2021

Mass cytometry for comprehensive immune profiling in CAR T cell

Mass cytometry for comprehensive immune profiling in CAR T cell

Sneha Ramakrishna

18 November 2021

Engineering new killers: bringing NK cells to the battle against cancer

Engineering new killers: bringing NK cells to the battle against cancer

T Laskowski, S Acharya, M Shanley

17 November 2021

Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Full spectrum flow cytometry: a powerful cytometric analysis to benefit cell therapy

Ana Leda Figueiredo Longhini

10 November 2021

Expert Insight

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

Artificial intelligence: accelerating translational cell therapy development through computational methods for neoepitope discovery

M Chiriva-Internati, L Piccotti, L Zammataro et al.

25 November 2021

Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Next-generation DNA vectors: is the nS/MARt platform a viable alternative to viruses for autologous T-cell immunotherapy?

Matthias Bozza, Richard Harbottle

23 November 2021

Interview

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

D Corey, J Rossi, R Vezan

25 November 2021

Critical success factors for tomorrow’s cellular immunotherapies

Critical success factors for tomorrow’s cellular immunotherapies

Peter Emtage

17 November 2021

A question of control? Next steps for novel TIL therapeutics

A question of control? Next steps for novel TIL therapeutics

Jan ter Meulen MD PhD

17 November 2021

Enhancing the depth and durability of patient responses to CAR T cell therapy

Enhancing the depth and durability of patient responses to CAR T cell therapy

Jennifer Brogdon

17 November 2021

Podcast

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

New-generation T cell immunotherapy at the intersection of adaptive and innate immunity

25 November 2021

Expert Roundtable Video

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

I Riviére, M Kurtoglu, T Haq

22 November 2021

Expert Roundtable

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

Expert Roundtable: accelerating time to market for CAR-T cell therapies through translatable workflow

22 November 2021

Raw Material Sourcing

Innovator Insight

Understanding raw material performance: quality and consistency of cytokines for translation to the clinic

Understanding raw material performance: quality and consistency of cytokines for translation to the clinic

Bernd Leistler

17 October 2021

Interview

Key considerations and risk management best practice for placenta-derived cell therapy raw materials

Key considerations and risk management best practice for placenta-derived cell therapy raw materials

Ruth Goldberg, Lior Raviv

21 October 2021

Journal articles

Expert Insight

Clinical applications of gene and cell therapies: case studies for the relevance of precision medicine

Clinical applications of gene and cell therapies: case studies for the relevance of precision medicine

Oscar G Segurado, MD, PhD, Ruhong Jiang, PhD

2 November 2021

Innovator Insight

Midstream unit operations: unsung heroes in AAV process development

Midstream unit operations: unsung heroes in AAV process development

Ratish Krishnan, Matthew Roach

17 November 2021

Interview

Pioneering commercial CAR T cell therapy clinical development in India and South Asia

Pioneering commercial CAR T cell therapy clinical development in India and South Asia

22 October 2021

Playing the long game in gene therapy clinical development

Playing the long game in gene therapy clinical development

Jonathan D Schwartz

22 October 2021

Analyzing trends and opportunities in the advanced therapy tool and service provider sectors

Analyzing trends and opportunities in the advanced therapy tool and service provider sectors

David Anderson

26 October 2021

Establishing gene therapies as a relevant, recognized and accessible therapeutic category

Establishing gene therapies as a relevant, recognized and accessible therapeutic category

Tay Salimullah

10 November 2021

Key topics in advanced therapy manufacturing: quality, safety, and supply

Key topics in advanced therapy manufacturing: quality, safety, and supply

J PhD, P C. Smith, PhD, FRSB, H PhD

24 November 2021

Podcast

Key topics in advanced therapy manufacturing: quality, safety, and supply

Key topics in advanced therapy manufacturing: quality, safety, and supply

24 November 2021

FastFacts

Effective integration of adherent cell culture and process characterization using a perfusion/circulation platform

Effective integration of adherent cell culture and process characterization using a perfusion/circulation platform

Ann Rossi Bilodeau PhD

18 October 2021

Improving the enrichment of mononuclear cells for CAR T cell therapies: the importance of platelet depletion

Improving the enrichment of mononuclear cells for CAR T cell therapies: the importance of platelet depletion

Isabelle Dalle Fusine

17 November 2021

PATfix™ pDNA platform for monitoring pDNA purification process

PATfix™ pDNA platform for monitoring pDNA purification process

15 November 2021

Mass spectrometry-based AAV protein characterization

Mass spectrometry-based AAV protein characterization

Andrew Hanneman, PhD

23 November 2021